XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF EARNING (LOSS) BEFORE INCOME TAX

The Company’s U.S. and foreign loss before income taxes are set forth below:

 

   2022   2021 
   December 31, 
   2022   2021 
United States  $(7,251,228)  $(15,420,364)
Foreign   (12,706,165)   (41,011,337)
Total  $(19,957,393)  $(56,431,701)
SCHEDULE OF INCOME TAX EXPENSE BENEFITS

 

   December 31, 
   2022   2021 
Deferred tax benefit - United States  $   $ 
Deferred tax benefit - Foreign   1,486,060    7,454,805 
Total income tax benefit  $1,486,060   $7,454,805 
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The Company’s deferred tax assets and deferred tax liabilities consist of the following:

   2022   2021 
   December 31, 
   2022   2021 
Deferred tax assets:          
Net operating loss carryforwards  $8,927,330   $5,509,522 
Stock-based compensation   1,348,928    858,791 
Accrued bonus       121,051 
Research and development capitalized expenses   614,041     
Intangible amortization   54,141    23,204 
Other   33,453    35,456 
Less valuation allowances   (10,977,893)   (6,548,024)
Net deferred tax assets  $   $ 
           
Deferred tax liabilities:          
Indefinite lived intangible assets       (1,607,122)
Net deferred tax liabilities  $   $(1,607,122)
SCHEDULE OF OPERATING LOSS CARRY FORWARDS

The Company had the following potentially utilizable net operating loss tax carryforwards:

 

   2022   2021 
   December 31, 
   2022   2021 
Federal  $18,349,753   $9,411,533 
State  $16,892,754   $8,664,242 
Foreign  $16,377,435   $11,911,845 
SCHEDULE OF EFFECTIVE STATUTORY INCOME TAX RATE

The Company’s effective tax rate varied from the statutory rate as follows:

 

   December 31, 
   2022   2021 
Federal income tax at the statutory rate   (21.0)%   (21.0)%
State income tax rate (net of federal)   (2.6)%   (1.0)%
Foreign tax rate differential   (3.1)%   (4.0)%
Intangible asset impairment   %   4.3%
Non-deductive expenses   (4.0)%   1.4%
Change in valuation allowance   23.3%   7.0%
Effective income tax rate   (7.4)%   (13.3)%